Correvio Pharma Corp Net Income per Employee (CORV), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Correvio Pharma Corp   (CORV)
 

Correvio Pharma Net Income per Employee

CORV's Quarterly Results, Trends, Rankings, Statistics
Correvio Pharma Corp recorded a cumulative net loss of $-35 million during 12 month ending in the fourth quarter 2019.
The Healthcare sector has seen employees of 171 other companies achieving higher income per employee. While Correvio Pharma 's total ranking has deteriorated compared to the previous quarter from 0 to 3869.


What is Income per Employee Ratio?






CORV Net Income per Employee (Dec 31 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -325,778 -153,509 -153,509 -153,509 -153,509
CORV's Total Ranking # 3869 # 0 # 0 # 0 # 0
Seq. Net Income Change - - - - -


CORV Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 172
Healthcare Sector # 447
Overall Market # 3869

Net Income per Employee Statistics
High Average Low
$ -153,509 $ -251,772 $ -325,778
(Dec 31 2018)   (Dec 31 2019)







Companies with similar Income per Employee for 12 month ending Dec 31 2019, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2019Number of Employees Dec 31 2019


Date modified: 2026-09-08T15:09:54+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.